|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/15 | (2006.01) |
| C12N 7/00 | (2006.01) |
| (11) | Number of the document | 2272532 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10176849.7 |
| Date of filing the European patent application | 2004-08-31 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-10 |
| (46) | Date of publication of the claims translation | 2016-04-11 |
| (30) | Number | Date | Country code |
| 499430 P | 2003-09-02 | US | |
| 0414787 | 2004-07-01 | GB |
| (72) |
Colau, Brigitte Desiree Alberte, BE
De Vos, Beatrice Arsene Virginie, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Rotaviruso vakcina |
| Rotavirus vaccine |
| Payment date | Validity (years) | Amount | |
| 2023-07-20 | 347.00 EUR |